## min read

BPD vs Bipolar: What’s the Difference?

By

Sonia Garcia

|

March 23, 2026

Summarize with AI

BPD vs Bipolar: What’s the Difference?

Table of Contents

Example H2
Example H3
Example H4
Example H5
Example H6

Both conditions are more common than many people assume. Mental Health America estimates a 5.9% lifetime prevalence for borderline personality disorder (BPD) and notes that patients with a BPD diagnosis may represent about 20% of the psychiatric inpatient population. The World Health Organization reports that in 2021, approximately 37 million people worldwide (0.5%) were living with bipolar disorder. These are not rare diagnoses and in real-world clinical settings, both appear frequently, sometimes in overlapping presentations.

That overlap is where confusion begins. The symptoms can look similar on the surface: mood instability, impulsivity, depression, irritability, and relationship strain. Many people find themselves questioning their diagnosis, reading conflicting information online, or starting treatment that doesn’t fully address what’s actually happening.

In this guide, we’ll break down each condition clearly, focusing on differences in timing, episode structure, triggers, and long-term patterns. We will explain how clinicians distinguish bipolar disorder and borderline personality disorder, so you can move toward a more accurate understanding and seek the appropriate care.

What Is Borderline Personality Disorder?

Borderline personality disorder (BPD) is a mental health condition marked by long-standing erratic patterns in emotion regulation, relationships, self-image, and impulse control. It isn’t a character flaw. Many people can function well day to day, yet experience intense inner distress, especially in close relationships. Symptoms tend to persist over time and may affect judgment, communication, and stability when stress rises, and self-doubt often occurs.

Common features include:

  • Fear of abandonment or separation sensitivity
  • Intense, fast-shifting emotions
  • Unstable relationship patterns
  • Shifting self-image or goals
  • Impulsive reactions under distress
  • Chronic emptiness
  • Anger that is hard to calm

Key Symptoms and Patterns in BPD

In BPD, shifts in mood are often reactive to interpersonal stress (conflict, distance, or perceived rejection) and can change within minutes to hours. The signal is the pattern over time and the impact on functioning, not a single “bad day.” People may notice that reassurance helps briefly, emotions don’t return to baseline quickly or easily, and impulses rise under distress.

  • Emotions: Intense spikes, slow recovery
  • Relationships: Closeness–doubt swings
  • Sense of self: Unstable identity
  • Behaviors: Urgent contact, impulsive choices

What Is Bipolar Disorder?

Bipolar disorder is a mood disorder defined by distinct episodes of depression and mania or hypomania that last days to weeks, sometimes longer. These are not ordinary mood swings. Episodes involve clear shifts in energy, sleep, activity level, and judgment that affect daily functioning. Between episodes, many people return to a more stable baseline.

Understanding how bipolar disorder unfolds over time is essential when comparing BPD vs bipolar disorder, because the timing and structure of mood changes are different.

Common episode features include:

  • Elevated or irritable mood during mania/hypomania
  • Decreased need for sleep without fatigue
  • Increased goal-directed activity or impulsive decisions
  • Depressive episodes with low energy and loss of interest
  • Impaired judgment during elevated states

Key Symptoms and Patterns in Bipolar Disorder

Bipolar disorder shows up as clearly defined episodes, not moment-to-moment shifts. Mood states persist and noticeably affect functioning at work, school, or in relationships. The intensity and duration are central to diagnosis:

  • Mania: Markedly elevated or irritable mood, reduced sleep, risky decisions, significant functional impact
  • Hypomania: Similar but less severe, still noticeable change in behavior
  • Depression: Sustained low mood, fatigue, slowed thinking, reduced functioning

Borderline Personality Disorder vs Bipolar Disorder: The Key Differences

Episode Duration and Timing

A core difference is how long mood and behavior changes typically last. In bipolar disorder, manic, hypomanic, and depressive episodes usually persist for days to weeks, sometimes longer, and create a sustained shift from a person’s baseline. In BPD, emotional changes can be faster and more reactive, often rising and settling within minutes to hours. Timing alone doesn’t confirm a diagnosis, but it is a useful clinical clue when assessing patterns over time.

Triggers: Reactive vs Episodic

Another distinction is what tends to set symptoms in motion. BPD shifts are often linked to interpersonal stress, like conflict, distance, misunderstanding, or perceived rejection, and the emotional response may feel immediate and intense. Bipolar episodes can emerge without a clear external trigger, even though stress, sleep disruption, and substances may contribute. The goal is not to “blame” triggers, but to understand what reliably precedes symptom changes, which helps guide assessment and treatment planning.

Identity and Relationships

BPD commonly involves an unstable sense of self and intense relationship patterns that can swing between closeness and distrust. People may feel uncertain about who they are, what they want, or how they should be with others, especially under stress. Bipolar disorder can also strain relationships, but often primarily during mood episodes when energy, judgment, and behavior change significantly. This contrast between bipolar disorder and borderline personality disorder is one reason clinicians focus on long-term patterns, not isolated moments.

Symptoms That Overlap

Some symptoms can appear in both conditions, which is why a professional assessment matters. Mood changes, irritability, impulsivity, and symptoms of depression or anxiety can look similar on the surface, especially when someone is under stress. Clinicians focus on the full history, episode patterns, and functional impact over time to clarify what is driving the symptoms. Research has noted that symptomatic overlap between bipolar disorder and borderline personality disorder can contribute to diagnostic confusion when patterns are not carefully assessed.

Overlaps:

  • Mood instability
  • Irritability
  • Impulsive decisions
  • Depressive symptoms
  • Anxiety symptoms

Diagnostic indicators:

  • Sustained episodes with clear baseline shifts
  • Rapid reactivity linked to interpersonal stress
  • Consistent patterns in self-image and relationships

Can You Have Bipolar Disorder and Borderline Personality Disorder?

Co-occurrence can happen, and it can make the clinical picture more complex - especially when mood episodes and interpersonal reactivity overlap. In these cases, treatment is most effective when it is individualized and based on careful tracking of symptoms over time. The goal is to identify which symptoms reflect episodic mood shifts, which reflect longer-term regulation patterns, and what supports stability in daily life. With a clear formulation, there is a plan: targeted therapy, monitoring, and coordinated care.

Area Can show up in both What clinicians look for
Mood Depression, irritability Episode length vs rapid reactivity
Behavior Impulsivity Context, triggers, functional impact
Anxiety Worry, agitation Timing, persistence, co-occurring disorders
Relationships Conflict, strain Baseline patterns vs episode-linked changes

How Diagnosis Works: Borderline Personality Disorder vs Bipolar Disorder

Diagnosis is based on a careful clinical history over time, not a single quiz or symptom checklist. Clinicians look at the pattern, duration, and severity of mood changes, what tends to trigger them, and how symptoms affect sleep, judgment, work, and relationships. Providers often track episodes across weeks or months and may use structured interviews to clarify patterns. They also rule out medical conditions, substance use, trauma-related symptoms, and medication effects that can mimic mood instability before confirming a diagnosis.

Treatment Differences: What Actually Helps

Treatment is most effective when it aligns with the underlying condition. In bipolar disorder and borderline personality disorder, the focus of care differs because the mechanisms driving symptoms are different:

  • For bipolar disorder, treatment prioritizes mood stabilization and prevention of future episodes. This typically includes medication management, psychotherapy, and structured daily routines that protect sleep and reduce relapse risk. The goal is to minimize episode frequency and intensity while preserving long-term functioning.
  • For BPD, treatment usually centers on structured psychotherapy that builds emotional regulation, distress tolerance, and interpersonal effectiveness. Dialectical Behavior Therapy (DBT) is one of the most established approaches. The goal is greater emotional stability, safer coping strategies, and more consistent relationship patterns over time.

Getting Care at Amae Health

At Amae Health, care begins with a structured, evidence-based assessment designed to clarify diagnosis and guide treatment planning. Our team evaluates symptom history, episode patterns, functional impact, and co-occurring conditions before making recommendations. We provide clear diagnostic feedback, individualized treatment plans, and ongoing monitoring to track progress and adjust care when needed.

Depending on your needs, treatment may include our Intensive Outpatient Program (IOP) or Partial Hospitalization Program (PHP), along with psychiatric support and skills-based therapy.

If you’re ready for clarity, stability, and evidence-based treatment, schedule a confidential evaluation or consultation today.

‍

Reccomended for you

# min read

Can Stress Cause Hallucinations?

By

Sonia Garcia

|

May 23, 2025

Stress can push the brain to its limits, sometimes distorting perception and creating sensory experiences that feel real but aren’t. While commonly associated with psychotic disorders, hallucinations can also emerge from extreme fatigue, chronic anxiety, or prolonged emotional distress. When stress overwhelms the nervous system, it disrupts normal sensory processing, leading to misinterpretations of reality.

Stress-induced hallucinations can be disorienting, temporarily affecting one’s ability to distinguish between reality and perception. Factors like sleep deprivation, heightened anxiety, and overstimulation can all contribute to these experiences. However, distinguishing between momentary stress-induced distortions and more serious medical concerns is crucial.

This article explores the link between stress and hallucinations, their causes, and when professional intervention is necessary. For those experiencing persistent or distressing hallucinations, seeking professional psychiatric evaluation at Amae Health can provide clarity and evidence-based treatment options.

What Causes Hallucinations?

Hallucinations occur when the brain perceives something that isn’t actually there — whether it’s sights, sounds, smells, or physical sensations. While often linked to psychotic disorders, they can also result from stress, sleep deprivation, and anxiety, which alter brain chemistry and disrupt sensory processing.

‍

Research suggests that stress-induced hallucinations may stem from dopamine and serotonin imbalances. Chronic stress can overactivate the limbic system, increasing dopamine levels, which is linked to hallucinations in psychotic disorders. The perceptual release theory also explains that when sensory input is reduced — due to exhaustion or stress — the brain “fills in the gaps” with internally generated images or sounds.

‍

Neuroimaging studies indicate that abnormal activation in the temporal and frontal lobes is associated with stress-related hallucinations. Understanding these mechanisms helps differentiate temporary hallucinations from more serious conditions.

Common Psychological and Medical Causes

Psychotic Disorders

Psychotic disorders, such as schizophrenia and schizoaffective disorder, are among the most well-known causes of hallucinations. These conditions affect the way the brain processes reality, leading to persistent auditory, visual, or tactile hallucinations. Individuals with psychotic disorders often experience delusions alongside hallucinations, making it difficult to differentiate between what is real and what is not.

Anxiety and Panic Disorders

Although less commonly associated with hallucinations, severe anxiety and panic disorders can lead to sensory distortions. During intense episodes, individuals may experience fleeting visual distortions, auditory misperceptions, or even a sense of detachment from reality. Hypervigilance and overstimulation from chronic anxiety can create a state where the brain misinterprets normal stimuli as hallucinations.

Sleep Deprivation and Fatigue

Lack of sleep can have profound effects on brain function, sometimes leading to hallucinations. Individuals suffering from extreme fatigue, insomnia, or conditions like sleep apnea may experience visual or auditory hallucinations, particularly in the form of fleeting images or phantom sounds. Sleep deprivation alters neurotransmitter levels, making it easier for the brain to misinterpret sensory input.

Substance Use or Withdrawal

Psychoactive substances, including alcohol, stimulants, and hallucinogenic drugs, can cause hallucinations both during use and withdrawal. Substances like LSD or psilocybin directly alter perception, while withdrawal from alcohol or benzodiazepines can lead to temporary hallucinations as the nervous system readjusts. Chronic substance abuse may also cause long-term changes in perception.

Chronic Stress (Hyperstimulation)

Prolonged exposure to stress can lead to a state of hyperstimulation, where the nervous system remains in overdrive. This heightened state of alertness can distort sensory processing, making individuals more susceptible to hallucinations. Chronic stress alters cortisol levels, impacting brain areas responsible for perception and memory, potentially leading to transient hallucinatory experiences.

How Can Stress Cause Hallucinations?

Dissociation as a Response to Stress

Dissociation is a defense mechanism triggered by overwhelming stress, leading to a sense of detachment from reality. A study published in Schizophrenia Bulletin Open found that individuals with a history of trauma are significantly more likely to experience hallucinations following acute stressors, reinforcing the link between stress, dissociation, and sensory distortions.

Individuals experiencing dissociation may feel disconnected from their surroundings, themselves, or time. In severe cases, dissociation can manifest as hallucinations, where the brain creates sensory experiences to cope with the overwhelming stress and emotional dysregulation.

Acute Stress and Hallucinations

Acute stress triggers the body's fight-or-flight response, flooding the system with stress hormones like cortisol and adrenaline. This heightened state of alertness can lead to sensory distortions, causing brief auditory or visual hallucinations. Individuals under extreme stress may misinterpret sounds, see fleeting images, or feel an unexplained presence due to heightened neural activity and hyper-awareness.

Chronic Stress (Hyperstimulation) and Its Impact

Chronic stress results in long-term hyperstimulation of the nervous system, altering brain chemistry and perception. Persistent stress can disrupt neurotransmitter balance, increasing susceptibility to hallucinations. Over time, heightened stress levels can cause hallucinations like auditory whispers, visual flashes, or phantom sensations as the brain struggles to filter sensory input properly.

Sleep Deprivation and Hallucinations

Stress often leads to sleep deprivation, which in turn increases the risk of hallucinations. Sleep deprivation disrupts cognitive processing, causing the brain to enter micro-dream states while awake. This can result in visual distortions, auditory misinterpretations, or a sensation of movement. The longer an individual goes without sleep, the more severe these hallucinations can become.

Types of Stress-Related Hallucinations

Auditory Hallucinations

Auditory hallucinations are among the most common stress-induced hallucinations. Individuals may hear whispers, distant voices, or even music when no external sound is present. These hallucinations can be disorienting, often occurring during periods of extreme anxiety or fatigue or after prolonged exposure to stress. According to research from Yale’s COPE Project, recent social stress directly correlates with both the frequency and distress levels of auditory hallucinations, highlighting the role of everyday stressors in exacerbating these experiences. Managing stress levels and improving sleep quality can help reduce these occurrences.

Visual Hallucinations

Visual hallucinations involve seeing objects, shapes, or figures that are not actually there. They can appear as fleeting shadows, flashes of light, or fully formed images. Stress-induced visual hallucinations often stem from sleep deprivation or severe emotional distress. Practicing relaxation techniques, mindfulness, and ensuring adequate rest can help minimize these experiences.

Tactile and Somatic Hallucinations

Tactile hallucinations create the sensation of physical touch when there is no actual contact. Individuals might feel crawling, tingling, or pressure on their skin. These can occur due to heightened anxiety, sleep deprivation, or intense stress. Grounding exercises and cognitive behavioral therapy (CBT) can be beneficial in managing these symptoms.

Olfactory and Gustatory Hallucinations

Olfactory hallucinations involve detecting smells that are not present, while gustatory hallucinations cause individuals to perceive unusual tastes. These can be triggered by prolonged stress, migraines, or neurological conditions. Identifying and managing stressors, along with medical evaluation, can help determine the cause and reduce their occurrence.

When Should You Be Concerned About Stress-Induced Hallucinations?

Signs You Should Seek Help

If hallucinations become frequent, intense, or start interfering with daily life, seeking professional help is essential. Persistent hallucinations, confusion, or distress warrant medical evaluation. Identifying underlying causes, such as extreme stress, sleep disorders, or mental health conditions, can help in developing an effective treatment plan to restore well-being.

How Are Stress-Related Hallucinations Treated?

Short-Term Coping Strategies

Immediate coping mechanisms include deep breathing, grounding techniques, and mindfulness exercises. Engaging in relaxation activities like meditation or progressive muscle relaxation can help reduce the intensity of hallucinations. Addressing stressors and improving sleep hygiene can also provide quick relief.

Long-Term Treatment Options

Managing stress-induced hallucinations requires a combination of professional and self-care approaches. Amae Health’s specialists offer evidence-based therapies, including cognitive behavioral therapy (CBT) and medication management, to help patients regain stability.

Therapy, such as cognitive behavioral therapy (CBT), can help address underlying stressors. In some cases, medication may be recommended. For individuals with chronic stress-induced hallucinations, psychiatric interventions such as medication targeting neurotransmitter regulation may provide significant relief. Lifestyle changes, including regular exercise, balanced nutrition, and structured routines, can further support mental and emotional well-being.

Regaining Control Over Stress-Induced Hallucinations

Stress-induced hallucinations can be disturbing, but they are often temporary and manageable with the right strategies. While occasional hallucinations caused by stress, sleep deprivation, or anxiety might not indicate a deeper issue, persistent or distressing experiences should not be ignored. 

Seeking professional help, practicing stress management techniques, and maintaining a healthy lifestyle can significantly reduce the risk of experiencing hallucinations. If you or someone you know is struggling with stress-related hallucinations, remember that support is available, and addressing the root cause can lead to long-term relief.

At Amae Health, our specialized team provides comprehensive care for stress-related mental health challenges. Schedule a consultation today to regain clarity and control over your well-being.

FAQ

Can anxiety cause hallucinations? 

Yes, severe anxiety and chronic stress can contribute to hallucinations, particularly auditory or visual ones. Anxiety-induced hallucinations often occur during heightened distress or panic attacks.

Are stress hallucinations dangerous? 

While stress-induced hallucinations can be distressing, they are not inherently dangerous. However, they may indicate underlying mental health concerns that require attention.

Do hallucinations from stress go away on their own? 

In many cases, stress-related hallucinations subside once the underlying stressor is managed. Prioritizing stress reduction, proper sleep, and relaxation techniques can help accelerate recovery. If hallucinations persist, seeking medical guidance is recommended.

‍

# min read

What Is Quiet Borderline Personality Disorder (BPD)?

By

Sonia Garcia

|

November 3, 2025

Quiet Borderline Personality Disorder is a subtype of borderline personality disorder in which emotional symptoms are directed inward rather than expressed outwardly. It involves hidden mood swings, emotional suppression, and social withdrawal.

Unlike typical BPD, which often includes visible emotional reactions, Quiet BPD is marked by internalized distress and self-directed feelings. Recent research highlights this pattern as an "internalizing subtype" of BPD or sometimes "discouraged type", where individuals experience significant emotional challenges that may not be outwardly visible. In this article, we explore how Quiet BPD differs from classic presentations, why it can be harder to recognize, and what steps can support those affected.

Exploring Quiet Borderline Personality Disorder

Borderline Personality Disorder (BPD) is typically associated with visible emotional outbursts, impulsive actions, and unpredictable mood swings. However, Quiet BPD presents differently. Individuals with Quiet BPD internalize their emotions rather than express them outwardly. Instead of outward anger or public displays of distress, they direct feelings inward, leading to self-blame, guilt, and deep-seated emotional isolation.

This internalization makes Quiet BPD much harder to recognize. The symptoms are hidden beneath a composed exterior, causing both the individual and those around them to overlook the struggle. People with Quiet Borderline Personality Disorder might appear calm on the surface while experiencing intense internal emotional turmoil. This contrast between appearance and reality can delay diagnosis and make sufferers feel even more alone, as they often believe their pain is invisible to others.

Key Symptoms and Signs of Quiet BPD

People with Quiet BPD experience intense emotional distress, but instead of expressing it outwardly, they turn it inward. The table below outlines the key differences between typical Borderline Personality Disorder (BPD) and Quiet BPD, highlighting how the same underlying condition can present in very different ways.

Typical BPD Quiet BPD
Outbursts of anger or frustration Suppressed anger, directed inward
Impulsive behaviors (substance use, reckless actions) Self-sabotage, procrastination, perfectionism
Visible mood swings Hidden emotional turmoil
Fear of abandonment, often expressed outwardly Silent fear of rejection, internalized anxiety
Seeking reassurance from others Withdrawing socially, avoiding attention

Core emotional patterns of Quiet BPD:

  • Chronic self-criticism: Persistent feelings of worthlessness and self-doubt.
  • Shame and guilt: Overwhelming internalized blame, even for minor mistakes.
  • Fear of abandonment: Deep anxiety about being left or rejected, yet fear of expressing these feelings.
  • Emotional numbness: Episodes of emptiness and detachment from feelings.

Behavioral signs of Quiet BPD:

  • Social withdrawal: Avoiding close connections out of fear of being a burden.
  • Overthinking: Obsessively replaying conversations and fixating on perceived mistakes.
  • Physical symptoms: Tension headaches, fatigue, and physical signs of chronic stress.
  • Perfectionism: Setting unrealistically high standards as a way to prevent rejection.

Recognizing these hidden patterns is crucial. Quiet Borderline Personality Disorder might not be obvious at first glance, but the internal struggle is very real - and understanding these signs as well as causes and risks is the first step toward support and healing.

Causes and Risks of Quiet BPD

Genetic Factors

A family history of mood disorders or BPD can increase susceptibility to Quiet BPD. Genetics play a role in emotional regulation and sensitivity, laying the groundwork for potential challenges. Certain genetic markers are associated with heightened emotional responses, which, if left unmanaged, can contribute to the development of Quiet BPD.

Environmental influences

Early emotional neglect, inconsistent parenting, and invalidation of feelings are well-documented contributors to Quiet BPD. The 2022 case report describes how patients with discouraged-type BPD, which reflects the same internalized patterns seen in Quiet BPD, often report a history of emotional bullying and lack of familial warmth, fostering emotional inhibition and persistent feelings of inadequacy (Roman et al., 2024). These patterns teach individuals to suppress emotions and rely on internal coping mechanisms.

Trauma and adversity

Childhood trauma, bullying, or prolonged emotional stress can shape the internal coping strategies typical of Quiet Borderline Personality Disorder. Experiencing chronic criticism or emotional abuse teaches individuals to anticipate rejection and blame themselves for negative experiences. Rather than externalizing pain, they learn to internalize it as a survival mechanism, believing it is safer to turn their distress inward.

How Quiet BPD Affects Daily Life

Living with Quiet Borderline Personality Disorder often involves an ongoing emotional burden. Persistent self-criticism erodes self-esteem and leads to exhaustion. In the workplace, perfectionism and fear of failure may cause burnout or missed opportunities. Relationships suffer as individuals withdraw, fearing rejection or being a burden.

Social isolation becomes both a coping mechanism and a source of deeper loneliness. Mental health often declines as these patterns persist, increasing the risk of depression and anxiety. Despite appearing functional, individuals with Quiet BPD often cope with persistent internal emotional distress.

Treatment Options

Psychotherapy

Psychotherapy remains the cornerstone of treatment for Quiet Borderline Personality Disorder. Two main approaches include:

  • Dialectical Behavior Therapy (DBT): Teaches emotional regulation, distress tolerance, and relationship skills. Helps manage overwhelming feelings and build healthier patterns.
  • Cognitive Behavioral Therapy (CBT): Focuses on identifying and reframing destructive thought patterns, promoting positive self-beliefs.

In particular, clinical research has shown that individuals with discouraged-type BPD - the clinical profile closely related to Quiet BPD - respond well to therapies that focus on building self-esteem and addressing internalized emotional distress. 

In addition to these approaches, therapy offers a consistent and safe environment where individuals can explore difficult emotions, understand the roots of their internal struggles, and gradually build healthier coping strategies. With time and commitment, psychotherapy empowers people with Quiet BPD to transform inner turmoil into personal growth and resilience.

Medication

Although there is no medication that specifically targets BPD, certain prescriptions can help manage co-occurring symptoms like anxiety, depression, or mood instability.

Common medications include:

  • Antidepressants: Help manage persistent sadness and anxiety.
  • Mood stabilizers: Reduce mood swings and emotional extremes.
  • Anti-anxiety medications: Provide short-term relief from acute distress.

Medication is often most effective when combined with therapy, creating a balanced treatment approach. It’s important to work closely with a psychiatrist to adjust medications for the best possible support of emotional well-being.

Support Groups

Support groups create a vital sense of community for individuals with Quiet Borderline Personality Disorder. They provide opportunities to:

  • Share experiences in a safe, understanding environment.
  • Learn coping strategies from peers.
  • Receive emotional validation and reduce feelings of isolation.

Support groups can complement professional therapy by reinforcing lessons learned and encouraging consistent self-care. The encouragement and solidarity found in these spaces can be deeply healing and empowering.

Mindfulness and Self-compassion

Mindfulness and self-compassion practices play a crucial role in managing Quiet BPD. These techniques include:

  • Mindfulness meditation: Helps individuals observe their thoughts without judgment.
  • Deep breathing exercises: Promotes relaxation and reduces anxiety.
  • Body scans: Encourages awareness of physical sensations to ground in the present moment.
  • Self-compassion exercises: Replaces harsh inner criticism with empathy and understanding.

These practices help break the cycle of rumination and self-blame, building emotional resilience and a healthier self-relationship.

Start Your Healing Journey with Quiet BPD Support

If you see yourself in these experiences, it’s important to remember that healing is not only possible - it’s within reach. Quiet Borderline Personality Disorder may make you feel invisible or misunderstood, but you’re not alone! 

At Amae Health, our compassionate team understands the unique struggles of living with internalized pain. We offer personalized treatment plans, emotional guidance, and a supportive environment where your story matters. You deserve care that meets you where you are - with empathy, patience, and expertise. 

Don’t wait in silence. Take that first step today and begin building a life rooted in self-understanding and resilience. Reach out to Amae Health.

# min read

TMS vs Ketamine and Spravato for Treatment-Resistant Depression

By

Sonia Garcia

|

October 5, 2026

f you are comparing TMS, ketamine, and Spravato for depression, you have probably reached the point where standard antidepressants have not done enough. All three are evidence-based options for treatment-resistant depression, and beyond that they have little in common. TMS is a course of magnetic stimulation delivered while you sit awake in a chair. Ketamine is an anesthetic given by IV, used off-label for depression. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that make up ketamine, with its own FDA approval and its own rulebook.

‍

None of the three is universally better. They differ in mechanism, speed, setting, and monitoring, and the right one depends on your clinical history and how you respond. Treatment-resistant depression generally means depression that has not adequately improved after at least two antidepressants taken at a proper dose for long enough, and that is the group where all three are most often used.

What Is TMS?

Transcranial magnetic stimulation uses a coil placed against the scalp to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region involved in mood regulation. The FDA first cleared TMS for major depressive disorder in 2008, according to the National Institute of Mental Health. It is delivered in an office, with no anesthesia and no medication.

‍

Our standard TMS course runs 20 to 30 daily sessions over four to six weeks, each 30 to 40 minutes long. You stay awake throughout and drive yourself home afterward. In real-world outcome data from 42 U.S. practices, more than half of patients with medication-resistant depression responded to a standard course, and more than a third reached remission.

What Is Ketamine Therapy?

Ketamine has been an FDA-approved anesthetic since 1970. Its use for depression is off-label: prescribed for a purpose the FDA has not formally approved, which is legal and common in medicine but leaves the safeguards less standardized. It is usually given as an IV infusion in a monitored clinic, as a series of sessions over a few weeks.

‍

Ketamine blocks the NMDA receptor, a glutamate receptor, rather than acting on serotonin like standard antidepressants, and that difference is thought to explain its speed. In a landmark 2006 trial, 18 people with treatment-resistant depression received a single infusion of 0.5 mg/kg, and their symptoms improved significantly within 110 minutes. By the next day, 71% had responded and 29% were in remission. One week later, 35% still met the response threshold. Rapid, real, and often short-lived.

‍

The catch is in the monitoring. Ketamine causes dissociation, a sense of detachment from your body or surroundings, plus sedation and blood pressure rises during and after the infusion, so you are observed until those effects pass and cannot drive that day. In a 2017 consensus statement in JAMA Psychiatry, an American Psychiatric Association task force found the evidence for rapid antidepressant effects convincing but the studies small, the longer-term efficacy data lacking, and the safety data on repeated dosing limited.

What Is Spravato (Esketamine)?

Ketamine is a mixture of two mirror-image molecules. Spravato is esketamine, one of those two, delivered as a nasal spray. Unlike IV ketamine, it has FDA approval for depression. The original approval came in March 2019 for treatment-resistant depression alongside an oral antidepressant, a second indication followed for adults with major depressive disorder and acute suicidal thoughts or behavior, and in January 2025 the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression, with no oral antidepressant required, per the current prescribing information.

‍

That approval comes with a rulebook. Spravato can only be given at a setting certified under a Risk Evaluation and Mitigation Strategy (REMS) program: you take the spray under supervision, you are monitored for at least two hours before an assessment clears you to leave, and you cannot drive until the next day after a restful sleep. Its label carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in younger patients.

‍

So is Spravato the same as ketamine? Related, not identical: same molecular family, same receptor, similar rapid onset and dissociative effects, but a different route, a formal FDA indication, and mandatory monitoring rules that off-label ketamine does not carry. For most people comparing TMS vs Spravato, those rules and insurance coverage are the practical differences that matter.

TMS vs Ketamine vs Spravato: Side-by-Side Comparison

Feature TMS IV ketamine Spravato (esketamine)
Mechanism Magnetic pulses stimulate the prefrontal cortex NMDA receptor antagonist, given intravenously NMDA receptor antagonist, nasal spray
FDA status Cleared for MDD (2008) and OCD (2018) Approved as an anesthetic; off-label for depression Approved for TRD (2019 with an oral antidepressant; 2025 as monotherapy) and for MDD with acute suicidal ideation
Onset Gradual, across a multi-week course Hours to days Hours to days
Session format 30 to 40 minutes, awake, in an office Infusion in a monitored clinic Self-administered spray under supervision in a certified setting
Monitoring None after the session Observed during and after the infusion At least two hours after each dose
Driving Drive yourself home Not that day Not until the next day
Typical course 20 to 30 daily sessions over 4 to 6 weeks A series of infusions over several weeks, then maintenance as needed Twice a week for the first four weeks, then weekly, with later dosing individualized
Common side effects Scalp discomfort, headache Dissociation, sedation, blood pressure rise, nausea Dissociation, dizziness, nausea, sedation, vertigo, raised blood pressure

Onset and Duration of Effect

Speed is the clearest dividing line. TMS builds gradually, and many people do not notice a clear change until the second or third week or later. Ketamine and Spravato can shift symptoms within hours to days.

‍

Speed and staying power are different things. Ketamine's effect after a single infusion often fades within a week or two, which is why it is given as a series with maintenance dosing. Spravato starts at twice a week and tapers, with the need for continued treatment reassessed along the way. Research on durability is still developing for all three, and none should be described as permanent.

Side Effects and Safety Considerations

TMS side effects are local and short-lived: scalp discomfort where the coil sits, headache, and sometimes brief lightheadedness or facial muscle twitching during the pulses. These usually settle within the first week, and because nothing enters the bloodstream there is no weight gain, sexual dysfunction, or sedation. Seizure is the one serious risk, exceedingly rare, and TMS is not used in people with a seizure history, metal in the head, or implanted electronic devices.

‍

Ketamine and Spravato share a different profile. The most common reactions to Spravato in trials were dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. Those effects peak in the hours after dosing, which is what the monitoring window is for, and both drugs carry a potential for misuse that shapes who is a candidate. Each option has its own screening, and a contraindication to one does not rule out the others.

Cost and Insurance

For TMS, most commercial insurers cover treatment for major depressive disorder once eligibility criteria are met, typically a confirmed diagnosis and documented antidepressant trials without adequate relief. Prior authorization is standard. For TMS we take all commercial insurance plans, cash pay is available, and authorization is something our intake team manages for you.

‍

Spravato is more commonly covered than off-label ketamine because it has an FDA indication insurers can write criteria around, though prior authorization and documentation of failed antidepressant trials are typically required. Ketamine infusion coverage varies widely, and many clinics are self-pay. Published cost estimates vary so much by dose, frequency, and insurance status that a single dollar figure would mislead; ask each provider and your insurer directly.

Can These Treatments Be Combined?

Sometimes, and the research is early. A 2024 systematic review found six published studies on combining TMS with ketamine, mostly case reports plus one retrospective review and one small pilot, and reported substantial and sustained improvement with generally mild side effects. The authors also said the designs were too varied and the samples too small for firm conclusions, and called for randomized trials.

‍

In practice, TMS and Spravato are sometimes used one after the other. Combining any of these is a clinical judgment a psychiatrist makes from your history, not a general recommendation, and the more common pattern is to use one, assess the response, then decide.

Choosing Between Them: What Influences the Decision

A psychiatrist weighing these options usually works through a short list:

‍

  • Treatment history. Which antidepressants, at what doses, for how long, and whether psychotherapy has been tried.
  • How urgently relief is needed. When symptoms are severe or suicidal thoughts are present, a faster-acting option may take priority, alongside care for suicidal thoughts.
  • Tolerance for the experience. Dissociation and a two-hour monitored window, versus a daily half-hour appointment for several weeks with no drug effects.
  • Practical constraints. Whether you can get to daily sessions, whether someone can drive you home after Spravato or ketamine, and what your insurance will authorize.
  • Health factors. Seizure history, metal implants, blood pressure, and any history of substance misuse each rule options in or out.
  • What else is in place. Any of the three works better inside ongoing psychiatric care and therapy than as a standalone fix.

Making the Decision With an Integrated Care Team

TMS, ketamine, and Spravato are tools, and tools do their best work inside a plan: a psychiatrist who knows your history, a therapist working alongside the biological treatment, and a team that notices when the plan needs to change.

‍

That is how we work. At Amae, our one-team care model combines psychiatry, therapy, primary care, and peer support, and TMS and Spravato are available through our Los Angeles and Bay Area clinics as part of that care. If you have been through the antidepressant cycle and want a clear, unhurried look at what comes next, talk with an Amae psychiatrist about your options. If you are in crisis or thinking about suicide, call or text 988 now.

Frequently Asked Questions

What is the difference between TMS and ketamine for depression?

TMS stimulates the brain with magnetic pulses over a course of daily outpatient sessions, with no drug, no sedation, and no monitoring afterward. Ketamine is a medication that acts on NMDA receptors, given by infusion or, as esketamine, by nasal spray, with monitored sedation and dissociation and often faster but shorter-lived effects.

Is Spravato the same as ketamine?

Related but not identical. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray under a required monitoring program. Ketamine infusions use the full ketamine compound and are prescribed off-label for depression, without an FDA indication for that use.

Is Spravato only approved with an antidepressant?

Not anymore. The original 2019 approval was for use alongside an oral antidepressant, and in January 2025 the FDA also approved Spravato as a standalone monotherapy for adults with treatment-resistant depression. Whether it is used alone or with an antidepressant is a decision your psychiatrist makes based on your situation.

Which works faster, TMS or Spravato?

Spravato. Esketamine and ketamine can produce symptom change within hours to days, while TMS builds gradually across a four-to-six-week course. Faster onset does not mean more durable improvement, and both durability and side effects belong in the comparison.

Can TMS and Spravato be used together?

Sometimes, as a clinical decision made with a psychiatrist based on your individual history. Both can be part of a broader treatment-resistant depression plan alongside medication and therapy, and the evidence on combining them is still early.

Is ketamine or Spravato covered by insurance?

Spravato is more commonly covered, because it has an FDA indication insurers can build criteria around, though prior authorization and proof of failed antidepressant trials are usually required. Coverage for off-label ketamine infusions varies widely and is often self-pay. Confirm with the provider and your insurer before starting.

‍

Citations

  1. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
  2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
  3. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006. https://pubmed.ncbi.nlm.nih.gov/16894061/ (Tier 1)
  4. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017. https://pubmed.ncbi.nlm.nih.gov/28249076/ (Tier 1)
  5. U.S. Food and Drug Administration. Drugs@FDA: SPRAVATO (esketamine), NDA 211243, approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243 (Tier 2)
  6. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf (Tier 2)
  7. Arubuolawe OO, Folorunsho IL, Busari AK, et al. Combination of transcranial magnetic stimulation and ketamine in treatment-resistant depression: a systematic review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/39156335/ (Tier 1, small-study review)
  8. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍